Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection

Note from the editors: novel coronavirus (2019-nCoV)

(2020)   Eurosurveillance

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

(2020) Timothy P. Sheahan et al.   Nature Communications

Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge

(2019) Michael K. Lo et al.   Science Translational Medicine

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics

(2019) Sabue Mulangu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets

(2018) Emmie de Wit et al.   ANTIVIRAL RESEARCH

Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission

(2018) David S Hui et al.   LANCET INFECTIOUS DISEASES

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

(2018) Maria L. Agostini et al.   mBio

Pathogenicity and Viral Shedding of MERS-CoV in Immunocompromised Rhesus Macaques

(2018) Joseph Prescott et al.   Frontiers in Immunology

First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease

(2017) Jenny Dörnemann et al.   JOURNAL OF INFECTIOUS DISEASES

Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset

(2017) Zhe Chen et al.   JOURNAL OF INFECTIOUS DISEASES

CEPI—a new global R&D organisation for epidemic preparedness and response

(2017) Børge Brende et al.   LANCET

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

(2017) Timothy P. Sheahan et al.   Science Translational Medicine

Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction

(2017) V M Corman et al.   Eurosurveillance

GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo- and Paramyxoviruses

(2017) Michael K. Lo et al.   Scientific Reports

Late Ebola virus relapse causing meningoencephalitis: a case report

(2016) Michael Jacobs et al.   LANCET

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

(2016) Travis K. Warren et al.   NATURE

A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation

(2016) Kayvon Modjarrad et al.   NATURE MEDICINE

Environmental Contamination and Viral Shedding in MERS Patients During MERS-CoV Outbreak in South Korea

(2015) Seo Yu Bin et al.   CLINICAL INFECTIOUS DISEASES

Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset

(2015) Jasper Fuk-Woo Chan et al.   JOURNAL OF INFECTIOUS DISEASES

Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset

(2014) Darryl Falzarano et al.   PLoS Pathogens

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

(2013) Abdullah Assiri et al.   LANCET INFECTIOUS DISEASES

Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques

(2013) Darryl Falzarano et al.   NATURE MEDICINE

Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques

(2013) E. de Wit et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA